Knowledge base · Peer-reviewed

ScaleWiki.

Peer-reviewed manuscripts on the G-Rex® platform — one citable page per paper, curated so you find the evidence that moves your cell & gene therapy program forward.

487Manuscripts indexed
14Cell types
Live indexContinuously updated

Showing 12 of 530 resources

Publications NK Cells G-Rex®6 Well Plate

Publication Date: November 10, 2023

Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer

An oncolytic adenovirus encoding a variant IL-2 (Ad5/3-E2F-d24-vIL2, TILT-452) boosted the killing activity of allogeneic NK cells against human ovarian cancer in ex vivo and mouse models. NK cells were expanded from healthy donor PBMCs and added at a 1:8 effector-to-target ratio to digests of twelve patient ovarian tumors together with virus at 100 vp per cancer cell. Combination treatment gave significantly higher cytotoxicity than NK cells alone in seven of 12 samples. In a patient-derived xenograft model, the combination gave the best tumor control and was significantly better than mock (p < 0.001) and NK monotherapy (p < 0.05). In tumors, granzyme B intensity in NK and CD8+ T c…

Download Now →

Author: D. C. A. Quixabeira, S. Pakola +16 more

Publications CAR T Cells

Publication Date: November 8, 2023

Targeting of intracellular oncoproteins with peptide-centric CARs

Peptide-centric chimeric antigen receptors (PC-CARs) targeting the unmutated PHOX2B peptide QYNPIRTTF eliminated neuroblastoma cells and drove complete tumour regression in mice. Immunopeptidomics was performed on eight neuroblastoma xenografts and eight high-risk primary tumours; filtering 9,117 peptide instances from the primary tumours left 56 neuroblastoma-specific peptides, and QYNPIRTTF from PHOX2B on HLA-A*24:02 was prioritized. Screening a Retained Display scFv library and filtering 25 CAR constructs with the sCRAP cross-reactivity algorithm selected clone 10LH, which bound the complex with 13 nM affinity. 10LH killed SKNAS, NBSD and SKNFI cells and released IFNγ within 24 h at a…

Download Now →

Author: Mark Yarmarkovich, Quinlen F. Marshall +26 more

Publications TCR T Cells, TIL Cells G-Rex®6M Well Plate

Publication Date: November 7, 2023

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes

A chimeric costimulatory antigen receptor (CoStAR) that links a folate receptor alpha-specific scFv to CD28 and CD40 signaling domains enhanced T cell function only when the T cell receptor was also engaged. In co-culture with OKT3-expressing targets, CD28.CD40 CoStAR T cells expanded 51.3-fold over four restimulations, versus 13.2-fold for non-transduced cells, and also proliferated without exogenous IL-2 while showing lower PD-1 expression. In mice bearing subcutaneous H508 tumors, T cells carrying a TCR plus CoStAR controlled tumor growth and survived longer, with or without IL-2. CoStAR-engineered TIL from ovarian, renal and lung tumors secreted 2.4- to 6.4-fold more IFNγ against auto…

Download Now →

Author: Milena Kalaitsidou, Owen R. Moon +17 more

Publications CAR T Cells

Publication Date: October 17, 2023

Context-specific synthetic T cell promoters from assembled transcriptional elements

Randomly ligating eleven transcription response elements upstream of an IL-2 minimal promoter produced a lentiviral library from which CD19CAR-directed screening in human CD8+ T cells isolated inducible synthetic promoters (iSynPros) that switch on only with antigen. Eight of eight candidates induced GFP at every recurrent CD19+ LCL exposure and returned to baseline, and iSynPro1 combined the tightest OFF state with the strongest induction. Induction required CD3 zeta signal 1, was abrogated by dasatinib, and did not follow costimulation alone. In mice, iSynPro1 activity stayed confined to antigen-bearing tumors. iSynPro1-driven LASI-7/21 cleared Nalm-6 in four of five mice with no deaths…

Download Now →

Author: Jacob Appelbaum, Jia Wei +15 more

Publications VST Cells G-Rex®6 Well Plate

Publication Date: October 13, 2023

The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses

T cells primed after SARS-CoV-2 infection or vaccination recognize most spike variants but show only partial cross-reactivity with omicron, and SARS-CoV-2-specific responses are largely distinct from those against endemic coronaviruses. Using 14-day microscale peptide priming of PBMCs from 32 healthcare workers and 13 immunocompromised patients, the authors found broad T cell responses to spike, membrane and nucleocapsid antigens in COVID-19 survivors. Omicron spike reactivity fell by a mean 47% in convalescent donors. Cells primed with endemic coronavirus antigens cross-recognized SARS-CoV-2 in some donors, whereas SARS-CoV-2-primed cells were less cross-reactive with common-cold antigen…

Download Now →

Author: Mithil K. Soni, Edoardo Migliori +12 more

Publications CAR T Cells, CD34 Cells, T-Cells G-Rex®6 Well Plate

Publication Date: October 6, 2023

Integrome signatures of lentiviral gene therapy for SCID-X1 patients

Lentiviral vectors integrate into a reproducible set of genomic addresses: across 273 samples from 10 infants treated for SCID-X1, more than 280,000 integration sites fell preferentially in introns of active genes, in super-enhancers near nuclear pore complexes, and above all in nuclear subcompartment A1, with over 60 percent of integration hotspots mapping there. Nine of the ten patients shared this pattern; the tenth, who had disseminated CMV infection at stem cell collection and a different clinical course, did not. The same signature appeared in clinical-grade CD19-CAR T cells. Gamma retroviral vectors entered compartment A1 far less often and targeted promoters more, which may bear o…

Download Now →

Author: Koon-Kiu Yan, Jose Condori +23 more

Publications CAR T Cells, T-Cells G-Rex®100M, G-Rex®6 Well Plate

Publication Date: October 5, 2023

Large-scale manufacturing of base-edited chimeric antigen receptor T cells

Circular RNA encoding the cytosine base editor BE4max disrupted PD-1 in primary human T cells more efficiently than linear mRNA, and supported manufacture of a clinical-scale dose of base-edited anti-CD19 CAR T cells. CircRNA was produced by Anabaena permuted intron-exon self-splicing with a mean circularization efficiency of 68.7%, and gave higher BE4max protein levels despite similar RNA decay, cutting the RNA requirement about 8-fold. In a semi-closed process, CD4+/CD8+ cells selected on the CliniMACS Prodigy were activated, nucleofected on day 2, transduced with an anti-CD19 CAR on day 3, and expanded 2- to 3-fold to about 1 × 10^8 cells by day 9. On-target C-to-T conversion reached 8…

Download Now →

Author: Rosie Woodruff, Farhaan Parekh +11 more

Publications TCR T Cells G-Rex®24 Well Plate

Publication Date: September 19, 2023

Identification of a small molecule for enhancing lentiviral transduction of T cells

A high-throughput screen of 27,892 compounds from a company small-molecule library identified GSK2622391 as a lead small molecule that enhances lentiviral transduction of T cells. Compounds were first tested with a GFP vector, and the top six were then tested with two TCR vectors targeting NY-ESO-1. GSK2622391 gave a statistically significant increase in transduction with both vectors without altering viability or fold expansion, and cytotoxicity and vector copy number stayed within set limits. Transcriptomic data suggested altered ribosome biogenesis and reduced interferon response. In an automated Prodigy process, the compound allowed a 3-fold reduction in vector volume, giving a compar…

Download Now →

Author: Paulina Malach, Charlotte Kay +9 more

Publications CAR T Cells

Publication Date: September 19, 2023

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

Combining CRISPR-Cas9 editing with Sleeping Beauty transposon delivery in a single electroporation step produced HLA-I and TCR knockout CD33-directed CAR-T cells that matched unedited CAR-T cells in phenotype and antitumor activity against acute myeloid leukemia models. Patient-derived CAR-T cells were more differentiated and exhausted and less effective in mice than healthy-donor cells, motivating the allogeneic approach. Edited cells showed 7.3 transposon copies on average versus 7.5 in unedited cells, with no significant off-target cleavage. Scaling up from 50 × 10^6 electroporated T cells, expansion in G-Rex® devices followed by magnetic selection gave at least 300 × 10^6 purified dou…

Download Now →

Author: Cristina Calviño, Candela Ceballos +21 more

Publications CAR T Cells G-Rex®6 Well Plate

Publication Date: September 13, 2023

Refining chimeric antigen receptors via barcoded protein domain combination pooled screening

A blunt-ligation cloning method that gives every CAR domain its own DNA barcode allowed pooled screening of 360 full-length CAR designs against CD19 and GD2 and identified two CD19 architectures that outperformed the Kymriah construct in mice. Libraries of 180 CARs per antigen were transduced into primary T cells and ranked by barcode frequency after repeated antigen stimulation and CellTrace Violet dilution. The hinge domain acted differently by target: the IgG4 short hinge favored CD19-CAR expansion, whereas the CD8a hinge favored GD2-CARs. In a Daudi lymphoma model, IgG4.4-1BB and IgG4.4-1BB.CD28 CARs gave better tumor control than CD8a.4-1BB, and IgG4.4-1BB improved survival. Barcodin…

Download Now →

Author: Xavier Rios, Osmay Pardias +10 more

Publications CAR T Cells

Publication Date: September 9, 2023

Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axis

A simple thaw/wash procedure removed nearly all DMSO from cryopreserved B7-H3-CAR T cell products while keeping them viable, sterile and functional for intracranial delivery to children with brain tumors. Thawed cells were equilibrated for 5 minutes with one volume of preservative-free normal saline, diluted with eight further volumes, washed by centrifugation and concentrated to a dose of 30 × 10^6 cells in 2 mL. Calculated DMSO fell from 5% to 0.0125–0.025%. In three validation products, final viability averaged 85.3% and viable cell recovery 76.5% of pre-cryopreservation values, endotoxin stayed at or below 0.05 EU/mL and sterility cultures were negative. Three hours after thaw, mean v…

Download Now →

Author: Salem Akel, Leigh Poston +9 more